CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-05 | DORSA CAROLINE Director | Sale | −4,686 | $82.35 | $386K | 6,210 |
| 2021-04-05 | DORSA CAROLINE Director | Sale | −800 | $82.99 | $66K | 5,410 |
| 2021-04-05 | DORSA CAROLINE Director | Option exercise · Stock Option (right to buy) | −7,500 | 9,088 | ||
| 2021-04-01 | LEONARD JOHN M President and CEO | Option exercise | +45,000 | $14.58 | $656K | 705,536 |
| 2021-04-01 | LEONARD JOHN M President and CEO | Sale | −24,314 | $84.00 | $2.0M | 681,222 |
| 2021-04-01 | LEONARD JOHN M President and CEO | Option exercise | +26,041 | $13.40 | $349K | 707,263 |
| 2021-04-01 | LEONARD JOHN M President and CEO | Sale | −13,895 | $83.00 | $1.2M | 693,368 |
| 2021-04-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −45,000 | 155,000 | ||
| 2021-04-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −26,041 | 273,959 | ||
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Option exercise | +33,000 | $13.88 | $458K | 148,842 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −2,010 | $80.79 | $162K | 146,832 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −8,266 | $81.89 | $677K | 138,566 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −3,233 | $82.76 | $268K | 135,333 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −3,234 | $83.91 | $271K | 132,099 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −1,067 | $84.94 | $91K | 131,032 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Option exercise | +21,000 | $18.30 | $384K | 152,032 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −1,256 | $80.82 | $102K | 150,776 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −4,818 | $81.83 | $394K | 145,958 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −2,728 | $82.63 | $225K | 143,230 |
| 2021-04-01 | Rivera Jose E EVP, General Counsel | Sale | −1,724 | $83.72 | $144K | 141,506 |
Page 23 of 40 · 783 trades